<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Caspian Journal of Internal Medicine</title>
<title_fa></title_fa>
<short_title>Caspian J Intern Med</short_title>
<subject>Medical Sciences</subject>
<web_url>http://caspjim.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-6164</journal_id_issn>
<journal_id_issn_online>2008-6172</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.22088/cjim</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Efficacy of Sucralfate Ointment in Prevention of Acute Proctitis in Cancer Patients: a Randomized Controlled Clinical Trial</title>
	<subject_fa>Oncology</subject_fa>
	<subject>Oncology</subject>
	<content_type_fa>Original Article</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;margin: 0px 0px 13.33px; text-align: justify; line-height: 200%;&quot;&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;em&gt;&lt;span style=&quot;color:#0000ff;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt;&lt;/span&gt;&lt;/em&gt; Acute radiation proctitis (ARP) is a usual adverse effect in patients undergoing pelvic radiotherapy. The symptoms include diarrhea, rectal blood or mucus discharge, fecal urgency and tenesmus with pain. Sucralfate, an aluminum-based salt of sucrose octasulfate, is a cytoprotective agent that forms a coating barrier at injured sites by adhering to mucoproteins. It has been used in topical management of a wide variety of local lesion. This study was designed to evaluate the preventive effect of rectal sucralfate on acute radiotherapy induced proctitis.&lt;br&gt;
&lt;em&gt;&lt;span style=&quot;color:#0000ff;&quot;&gt;&lt;strong&gt;Methods:&lt;/strong&gt; &lt;/span&gt;&lt;/em&gt;Seven percent sucralfate ointment was prepared for topical use. Drug quantification, chemical stability and microbial limit tests were performed carefully. In this randomized double blind placebo controlled trial, fifty-seven patients with pelvic malignancies undergoing radiotherapy were allocated to receive either 1 g of sucralfate or 1 g of placebo, given as a twice daily ointment, one day before and during radiotherapy for six weeks. The eligible patients were evaluated based on RTOG acute toxicity criteria and the following ARP symptoms weekly: rectal hemorrhage, diarrhea, rectal pain, and fecal urgency.&amp;nbsp; The influence of symptoms on lifestyle were also recorded weekly.&lt;br&gt;
&lt;em&gt;&lt;span style=&quot;color:#0000ff;&quot;&gt;&lt;strong&gt;Results:&lt;/strong&gt;&lt;/span&gt;&lt;/em&gt; Acute proctitis was significantly less prevalent in patients in the sucralfate group. The incidence of rectal bleeding (P=0.003), diarrhea (P= 0.002), rectal pain (P=&lt;0.001) and fecal urgency (P=0.002) were significantly less common in the sucralfate group. No statistically significant difference was observed for radiotherapy induced cystitis in the placebo and sucralfate groups (P=0.27).&lt;br&gt;
&lt;em&gt;&lt;span style=&quot;color:#0000ff;&quot;&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt;&lt;/span&gt;&lt;/em&gt; This study suggests that sucralfate7% ointment reduces the incidence of symptoms associated with acute radiation proctitis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Key words: Radiotherapy, Sucralfate, Acute Proctitis, Pelvic, Ointment</keyword>
	<start_page>410</start_page>
	<end_page>418</end_page>
	<web_url>http://caspjim.com/browse.php?a_code=A-10-1476-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Sara</first_name>
	<middle_name></middle_name>
	<last_name>Saei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>s.saei90@gmail.com</email>
	<code>100319475328460024930</code>
	<orcid>100319475328460024930</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Adeleh</first_name>
	<middle_name></middle_name>
	<last_name>Sahebnasagh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>masoomehsahebnasagh@gmail.com</email>
	<code>100319475328460024931</code>
	<orcid>100319475328460024931</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Surgical Medicine, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Arash</first_name>
	<middle_name></middle_name>
	<last_name>Ghasemi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>dr_arash_ghasemi@yahoo.com</email>
	<code>100319475328460024932</code>
	<orcid>100319475328460024932</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Emam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Jafar</first_name>
	<middle_name></middle_name>
	<last_name>Akbari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>jafakbari@gmail.com</email>
	<code>100319475328460024933</code>
	<orcid>100319475328460024933</orcid>
	<coreauthor>No</coreauthor>
	<affiliation> Pharmaceutical Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ali</first_name>
	<middle_name></middle_name>
	<last_name>Yaghobi Joybari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Ali_Yaghobi_Joybari@yahoo.com</email>
	<code>100319475328460024934</code>
	<orcid>100319475328460024934</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Buali Hospital, Tehran Medical Sciences Branch, Islamic Azad University,Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Farid</first_name>
	<middle_name></middle_name>
	<last_name>Nejad Dadgar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>fariddadgar2017@yahoo.com</email>
	<code>100319475328460024935</code>
	<orcid>100319475328460024935</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Buali Hospital, Tehran Medical Sciences Branch, Islamic Azad University,Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Shahram</first_name>
	<middle_name></middle_name>
	<last_name>Ala</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sh204ala@yahoo.com</email>
	<code>100319475328460024936</code>
	<orcid>100319475328460024936</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Pharmaceutical Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ebrahim</first_name>
	<middle_name></middle_name>
	<last_name>Salehifar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>salehifare@yahoo.com</email>
	<code>100319475328460024937</code>
	<orcid>100319475328460024937</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Gastrointestinal Cancer Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Abbas</first_name>
	<middle_name></middle_name>
	<last_name>Alipour</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>alipour.abbas59@gmail.com</email>
	<code>100319475328460024938</code>
	<orcid>100319475328460024938</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Faculty of Medicine, Community medicine department, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
